Document is current
Any future updates will be listed below
-
Authors
McPhee, Patrick G. https://orcid.org/0000-0001-5613-9755
Ball, Geoff D. C.
Buchholz, Annick
Hamilton, Jill K. https://orcid.org/0000-0002-1958-2800
Ho, Josephine https://orcid.org/0000-0003-0379-4427
Zenlea, Ian
Thabane, Lehana
Morrison, Katherine M.
,
Birken, Catherine
Chanoine, Jean-Pierre
Hadjiyannakis, Stasia
Laberge, Anne-Marie
Legault, Laurent
Tremblay, Mark S.
- License Information
-
More Information
Article History
Received: 1 November 2023
Revised: 26 August 2024
Accepted: 2 September 2024
First Online: 16 September 2024
Competing interests
: PGM, AB, JPC, AL, MST, JH and LT have no competing interests. IZ is an advisory board member for Novo Nordisk, Dexcom, and Abbot Diabetes Care. JKH is a site investigator for studies sponsored by Levo Therapeutics, Canada, Rhythm Pharmaceuticals and Eli Lilly, and an advisory board member for Novo Nordisk. GDCB and LL are advisory board members for Novo Nordisk. KMM is an advisory board member for Novo Nordisk and Akcea Therapeutics, Canada.
: The CANPWR study was approved by the following Research Ethics Boards: Hamilton Integrated Research Ethics Board, Conjoint Health Research Ethics Board (Calgary, Alberta), Research Ethics Board Trillium Health Partners, Health Research Ethics Board—Health Panel (Edmonton, Alberta), Children’s Hospital of Eastern Ontario Research Ethics Board, The Hospital for Sick Children Research Ethics Board, University of British Columbia Clinical Research Ethics Board, CHU Sainte-Justine Research Ethics Board, McGill University Health Centre Research Ethics Board—Pediatrics. All methods in the study were performed in accordance with the relevant guidelines and regulations of each Research Ethics Board. Written informed consent was obtained from the child’s parent or guardian, and participants provided assent.
